Matthew Herper and Jason Mast

BioTech

Moderna touts research progress as it cuts R&D spending by $1.1 billion

Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession

Matthew Herper and Jason Mast September 12, 2024

BioTech

Small studies offer hope CAR-T can fight an aggressive brain cancer

A series of new studies are raising hopes that CAR-T, a process in which treatments are made by genetically editing a patient’s own white blood

Matthew Herper and Jason Mast March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Matthew Herper and Jason Mast

Moderna touts research progress as it cuts R&D spending by $1.1 billion

Small studies offer hope CAR-T can fight an aggressive brain cancer

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe